Advertisement
Screener

AKEBIA THERAPEUTICS, INC. (AKBA) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

AKEBIA THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense and Other Assets

AKEBIA THERAPEUTICS, INC. (AKBA) reported Increase (Decrease) in Prepaid Expense and Other Assets of $2.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-05

  • AKEBIA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $2.17M.
  • AKEBIA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$170.00K.
  • AKEBIA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$1.56M.
  • AKEBIA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$2.50M.
  • AKEBIA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$7.58M.
  • AKEBIA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$8.89M.
  • AKEBIA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$11.84M.
  • AKEBIA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$1.06M, a 105.67% decline from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 85 month
2026-06-30$2.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$2.00M
10-Q · filed 2026-08-05
$442.00K
derived: sum of 3 quarters · filed 2026-08-05
-$2.06M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$170.00K
10-Q · filed 2026-05-07
-$1.73M
derived: sum of 2 quarters · filed 2026-05-07
-$4.23M
derived: sum of 3 quarters · filed 2026-05-07
-$5.54M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$1.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$4.06M
derived: sum of 2 quarters · filed 2026-02-26
-$5.37M
derived: sum of 3 quarters · filed 2026-08-05
-$7.58M
10-K · filed 2026-02-26
2025-09-30-$2.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$3.81M
derived: sum of 2 quarters · filed 2026-08-05
-$6.02M
10-Q · filed 2025-11-10
-$8.11M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30-$1.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$3.52M
10-Q · filed 2026-08-05
-$5.61M
derived: sum of 3 quarters · filed 2026-08-05
-$11.13M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$2.21M
10-Q · filed 2026-05-07
-$4.30M
derived: sum of 2 quarters · filed 2026-05-07
-$9.82M
derived: sum of 3 quarters · filed 2026-05-07
-$9.69M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$2.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$7.61M
derived: sum of 2 quarters · filed 2026-02-26
-$7.48M
derived: sum of 3 quarters · filed 2026-02-26
-$8.89M
10-K · filed 2026-02-26
2024-09-30-$5.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$5.39M
derived: sum of 2 quarters · filed 2025-11-10
-$6.80M
10-Q · filed 2025-11-10
-$8.60M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$130.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$1.28M
10-Q · filed 2025-08-07
-$3.08M
derived: sum of 3 quarters · filed 2026-02-26
-$5.44M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$1.41M
10-Q · filed 2025-05-08
-$3.21M
derived: sum of 2 quarters · filed 2026-02-26
-$5.57M
derived: sum of 3 quarters · filed 2026-02-26
-$5.87M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$1.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$4.16M
derived: sum of 2 quarters · filed 2026-02-26
-$4.46M
derived: sum of 3 quarters · filed 2026-02-26
-$11.84M
10-K · filed 2026-02-26
2023-09-30-$2.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$2.67M
derived: sum of 2 quarters · filed 2024-11-07
-$10.04M
10-Q · filed 2024-11-07
-$1.30M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30-$306.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$7.68M
10-Q · filed 2024-08-08
$1.06M
derived: sum of 3 quarters · filed 2024-08-08
-$8.18M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$7.38M
10-Q · filed 2024-05-09
$1.36M
derived: sum of 2 quarters · filed 2024-05-09
-$7.88M
derived: sum of 3 quarters · filed 2024-05-09
$583.00K
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$8.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14
-$497.00K
derived: sum of 2 quarters · filed 2024-03-14
$7.96M
derived: sum of 3 quarters · filed 2024-03-14
-$1.06M
10-K · filed 2024-03-14
-$381.00K
10-K · filed 2023-03-10
2022-09-30-$9.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
-$779.00K
derived: sum of 2 quarters · filed 2023-11-08
-$9.80M
10-Q · filed 2023-11-08
-$9.13M
10-Q · filed 2022-11-03
-$16.16M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30$8.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-28
-$561.00K
10-Q · filed 2023-08-28
-$6.92M
derived: sum of 3 quarters · filed 2023-08-28
$21.40M
derived: sum of 4 quarters · filed 2023-08-28
2022-03-31-$9.02M
10-Q · filed 2023-05-08
-$15.38M
derived: sum of 2 quarters · filed 2023-08-28
$12.94M
derived: sum of 3 quarters · filed 2023-08-28
$11.91M
derived: sum of 4 quarters · filed 2023-08-28
2021-12-31-$6.36M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28
$21.96M
derived: sum of 2 quarters · filed 2023-08-28
$20.93M
derived: sum of 3 quarters · filed 2023-08-28
$18.66M
10-K/A · filed 2023-08-28
2021-09-30$28.32M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$27.29M
derived: sum of 2 quarters · filed 2022-11-03
$25.02M
10-Q · filed 2022-11-03
$30.86M
derived: sum of 4 quarters · filed 2023-08-28
2021-06-30-$1.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$3.30M
10-Q · filed 2022-08-04
$2.54M
derived: sum of 3 quarters · filed 2023-08-28
$1.54M
derived: sum of 4 quarters · filed 2023-08-28
2021-03-31-$2.27M
10-Q · filed 2022-05-09
$3.57M
derived: sum of 2 quarters · filed 2023-08-28
$2.57M
derived: sum of 3 quarters · filed 2023-08-28
$3.95M
derived: sum of 4 quarters · filed 2023-08-28
2020-12-31$5.84M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28
$4.84M
derived: sum of 2 quarters · filed 2023-08-28
$6.22M
derived: sum of 3 quarters · filed 2023-08-28
$8.12M
10-K/A · filed 2023-08-28
2020-09-30-$998.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$381.00K
derived: sum of 2 quarters · filed 2021-11-04
$2.28M
10-Q · filed 2021-11-04
$1.15M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$1.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$3.28M
10-Q · filed 2021-08-05
$2.15M
derived: sum of 3 quarters · filed 2022-03-01
-$18.60M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$1.90M
10-Q · filed 2021-05-10
$772.00K
derived: sum of 2 quarters · filed 2022-03-01
-$19.98M
derived: sum of 3 quarters · filed 2022-03-01
-$7.33M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31-$1.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$21.88M
derived: sum of 2 quarters · filed 2022-03-01
-$9.22M
derived: sum of 3 quarters · filed 2022-03-01
-$10.54M
10-K · filed 2022-03-01
2019-09-30-$20.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$8.10M
derived: sum of 2 quarters · filed 2020-11-05
-$9.41M
10-Q · filed 2020-11-05
-$8.78M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$12.65M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$11.34M
10-Q · filed 2020-08-10
$11.97M
derived: sum of 3 quarters · filed 2021-02-25
$13.50M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$1.32M
10-Q · filed 2020-05-05
-$686.00K
derived: sum of 2 quarters · filed 2021-02-25
$846.00K
derived: sum of 3 quarters · filed 2021-02-25
-$1.84M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$631.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$2.16M
derived: sum of 2 quarters · filed 2021-02-25
-$519.00K
derived: sum of 3 quarters · filed 2021-02-25
$977.00K
10-K · filed 2021-02-25
2018-09-30$1.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$1.15M
derived: sum of 2 quarters · filed 2019-11-12
$346.00K
10-Q · filed 2019-11-12
$2.74M
derived: sum of 4 quarters · filed 2020-03-12
2018-06-30-$2.68M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
-$1.19M
10-Q · filed 2019-08-08
$1.21M
derived: sum of 3 quarters · filed 2020-03-12
-$6.01M
derived: sum of 4 quarters · filed 2020-03-12
2018-03-31$1.50M
10-Q · filed 2019-05-09
$3.89M
derived: sum of 2 quarters · filed 2020-03-12
-$3.33M
derived: sum of 3 quarters · filed 2020-03-12
$4.60M
derived: sum of 4 quarters · filed 2020-03-12
2017-12-31$2.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
-$4.83M
derived: sum of 2 quarters · filed 2020-03-12
$3.10M
derived: sum of 3 quarters · filed 2020-03-12
$4.19M
10-K · filed 2020-03-12
2017-09-30-$7.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$704.00K
derived: sum of 2 quarters · filed 2018-11-08
$1.80M
10-Q · filed 2018-11-08
$106.00K
derived: sum of 4 quarters · filed 2019-03-26
2017-06-30$7.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
$9.02M
10-Q · filed 2018-08-08
$7.33M
derived: sum of 3 quarters · filed 2019-03-26
$7.28M
derived: sum of 4 quarters · filed 2019-03-26
2017-03-31$1.09M
10-Q · filed 2018-05-09
-$598.00K
derived: sum of 2 quarters · filed 2019-03-26
-$646.00K
derived: sum of 3 quarters · filed 2019-03-26
$723.00K
derived: sum of 4 quarters · filed 2019-03-26
2016-12-31-$1.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26
-$1.74M
derived: sum of 2 quarters · filed 2019-03-26
-$370.00K
derived: sum of 3 quarters · filed 2019-03-26
-$428.00K
10-K · filed 2019-03-26
2016-09-30-$48.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
$1.32M
derived: sum of 2 quarters · filed 2017-11-08
$1.26M
10-Q · filed 2017-11-08
$2.49M
derived: sum of 4 quarters · filed 2018-03-12
2016-06-30$1.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
$1.31M
10-Q · filed 2017-08-08
$2.54M
derived: sum of 3 quarters · filed 2018-03-12
$1.70M
derived: sum of 4 quarters · filed 2018-03-12
2016-03-31-$58.00K
10-Q · filed 2017-05-09
$1.17M
derived: sum of 2 quarters · filed 2018-03-12
$333.00K
derived: sum of 3 quarters · filed 2018-03-12
$142.00K
derived: sum of 4 quarters · filed 2018-03-12
2015-12-31$1.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12
$391.00K
derived: sum of 2 quarters · filed 2018-03-12
$200.00K
derived: sum of 3 quarters · filed 2018-03-12
$1.00M
10-K · filed 2018-03-12
2015-09-30-$834.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$1.02M
derived: sum of 2 quarters · filed 2016-11-09
-$224.00K
10-Q · filed 2016-11-09
-$190.00K
10-Q · filed 2015-11-09
-$226.00K
derived: sum of 4 quarters · filed 2017-03-06
2015-06-30-$191.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$610.00K
10-Q · filed 2016-08-08
$608.00K
derived: sum of 3 quarters · filed 2017-03-06
$346.00K
derived: sum of 4 quarters · filed 2017-03-06
2015-03-31$801.00K
10-Q · filed 2016-05-05
$775.00K
10-Q · filed 2015-05-11
$799.00K
derived: sum of 2 quarters · filed 2017-03-06
$537.00K
derived: sum of 3 quarters · filed 2017-03-06
$767.00K
derived: sum of 4 quarters · filed 2017-03-06
2014-12-31-$2.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06
-$264.00K
derived: sum of 2 quarters · filed 2017-03-06
-$34.00K
derived: sum of 3 quarters · filed 2017-03-06
$686.00K
10-K · filed 2017-03-06
$773.00K
10-K · filed 2015-03-04
2014-09-30-$262.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
-$32.00K
derived: sum of 2 quarters · filed 2015-11-09
$688.00K
10-Q · filed 2015-11-09
$877.00K
derived: sum of 4 quarters · filed 2016-03-14
2014-06-30$230.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11
$950.00K
10-Q · filed 2015-08-11
$949.61K
10-Q · filed 2014-08-11
$1.14M
derived: sum of 3 quarters · filed 2016-03-14
$1.52M
derived: sum of 4 quarters · filed 2016-03-14
2014-03-31$720.00K
10-Q · filed 2015-05-11
$719.53K
10-Q · filed 2014-05-12
$909.00K
derived: sum of 2 quarters · filed 2016-03-14
$1.29M
derived: sum of 3 quarters · filed 2016-03-14
$1.20M
derived: sum of 4 quarters · filed 2016-03-14
$1.43M
10-Q · filed 2014-05-12
2013-12-31$189.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14
$573.16K
derived: sum of 2 quarters · filed 2016-03-14
$481.21K
derived: sum of 3 quarters · filed 2016-03-14
$217.00K
10-K · filed 2016-03-14
$167.00K
10-K · filed 2015-03-04
2013-09-30$384.16K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$292.21K
derived: sum of 2 quarters · filed 2014-11-10
$28.00K
10-Q · filed 2014-11-10
2013-06-30-$91.95K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
-$356.16K
10-Q · filed 2014-08-11
2013-03-31-$264.21K
10-Q · filed 2014-05-12
2012-12-31-$244.00K
10-K · filed 2015-03-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
MACROGENICS INC (MGNX)United States$0.242B-20.11
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33